Abstract
Immunosuppressed recipients of organ transplants have a higher incidence of carcinoma than the general population. A retrospective analysis was made at the Department of Urology of Bonn University, investigating 236 renal allograft recipients as to the incidence of neoplasms before and after transplantation. Eleven patients developed malignant tumours after transplantation. In 4 out of these 11 patients, case history showed pre-existing malignancies. Two of the 4 patients developed a second tumour, while the other two had tumour progression (latency period 21–77 months). Three of the 4 patients died of their tumours 21, 42 and 77 months after transplantation, whereas one female patient is still alive and free of neoplasms 32 months after transplantation. In 7 out of these 11 patientsde novo tumours were diagnosed (latency period 3–88 months). All of them are still alive (NED between 15 and 85 months), six of them with good transplant function. There was no difference to be seen in the incidence of malignancies between kidneys supplied by Eurotransplant (n=40) and ABO compatible kidneys from our own donors (n=196). The higher incidence rate of neoplasms in transplant recipients requires high standards in preventive measures. Any suspicious change that may occur in the course of a thorough follow-up of transplant recipients must be removed and examined histologically. Patients with previous malignant diseases must be payed special attention, since they frequently tend to develop another malignant tumour and progression of existing tumours, respectively.
As far as immunosuppression is concerned, therapeutic guidelines for the treatment of transplant recipients do not differ from those set up for patients on haemodialysis. Since immunosuppression with increased rates of tumour incidence can also be observed in dialysis patients, the mere fact of increased incidence of neoplasms cannot be taken as an argument against transplantation. With a more or less equal risk of tumour incidence the crucial factor should be the higher quality of life for transplant recipients.
Similar content being viewed by others
References
Blohme, I., Brynger, H.: Malignant disease in renal transplant patients.Transplantation, 39, 23 (1985).
Kinlen, L. J., Eastwood, J. B., Kerr, D. N. S., Moorhead, J. F., Oliver, D. O., Robinson, B. H. B., De Wardener, H. E., Wing, A. J.: Cancer in patients receiving dialysis.Br. Med. J., 1, 1401 (1980).
Penn, I.: Development of cancer as a complication of clinical transplantation.Transplant. Proc., 9, 1121 (1977).
Penn, I.: The occurrence of cancer in immune deficiencies.Curr. Probl. Cancer, 6 (10). 1 (1982).
Sheil, A. G. R.: Cancer after transplantation.World J. Surg., 10, 389 (1986).
Jacobs, C., Brunner, F. P., Brynger, H., Chantler, C., Donckerwolcke, R. A., Hathaway, R. A., Kramer, P., Selwood, N. H., Wing, A. J.: Malignant disease in patients treated by dialysis and transplantation in Europe.Transplant. Proc., 13, 729 (1981).
Sheil, A. G. R., Mahoney, J. F., Horvarth, J. S., Johnson, J. R., Tiller, D. J., Steward, J. H.: Cancer and survival after cadaveric donor renal transplantation.Transplant. Proc., 11, 1052 (1979).
Noronha, I. L., Ritz, E., Waldherr, R., Stein, G., Fassbinder, W.: Renal cell carcinoma in dialysis patients with acquired renal cysts.Nephrol. Dial. Transplant., 4, 763 (1989).
Sutherland, G. A., Glass, J., Gabriel, R.: Increased incidence of malignancy in chronic renal failure.Nephron, 18, 182 (1977).
Martin, D. C., Rubini, M., Rosen, V. J.: Cadaveric renal homotransplantation with inadvertent transplantation of carcinoma.JAMA, 192, 82 (1965).
McPhaul, J. J., McIntosh, D. A.: Tissue transplantation still vexes.N. Engl. J. Med., 272, 105 (1965).
Wilson, R. E., Hager, E. B., Hampers, C. L., Corsons, J. M., Merrill, J. P., Murray, J. E.: Immunologic rejection of human cancer transplanted with renal allograft.N. Engl. J. Med., 278, 479 (1968).
Zukowski, C. F., Killen, D. A., Ginn, E., Matter, B., Lucas, D. O., Seigler, H. F.: Transplanted carcinoma in an immunosuppressed patient.Transplantation, 9, 71 (1970).
Lindner, A., Farewell, V. T., Sherrard, D. J.: High incidence of neoplasia in uremic patients receiving long-term dialysis.Nephron, 27, 292 (1981).
Digenis, G., Pierratos, A., Oreopoulos, D. G.: Cancer and chronic renal failure.CMAJ, 135, 14 (1986).
Planz, B., Gladziwa, U., Sohn, M., Jakse, G.: Urologische Tumoren bei Patienten mit Niereninsuffizienz.Urologe [B],34, 430 (1994).
Slifkin, R. F., Goldberg, J., Neff, M. S., Baez, A., Mattoo, N., Gupta, S. Malignancy in end-stage renal disease.Trans. Amer. Soc. Artif. Intern. Org., 22, 34 (1977).
Starzl, T. E., Porter, K. A., Iwatsuki, S., Rosenthal, J. T., Shaw, B. W., Atchison, R. W., Nalesnik, M. A., Ho, M., Griffith, B. P., Hakala, T. R., Hardesty, R. L., Jaffe, R.: Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.Lancet, 1, 583 (1984).
Swanson, M. A., Schwarz, R. S.: Immunosuppressive therapy: The relation between clinical response and immunologic completence.N. Engl. J. Med., 277, 163 (1967).
Doak, P. B., Montgomerie, J. Z., North, J. D. K., Smith, F.: Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy.Br. Med. J., 4, 746 (1968).
Gentile, G., Formelli, G., Orsoni, G., Rinaldi, A. M., Busacchi, P.: Immunosuppression and human genital papilloma virus infection.Eur. J. Gynaecol. Oncol., 12, 79 (1981).
Penn, I.: Incidence and treatment of neoplasia after transplantation.J. Heart Lung Transplant., 12, 328 (1993).
Birkeland, S. A.: Malignant tumors in renal transplant patients. The Scandia transplant material.Cancer, 51, 1571 (1983).
Dyall-Smith, D., Trowell, H., Mark, A., Dyall-Smith, M. L.: Cutaneous squamous cell carcinomas and papilloma viruses in renal transplant recipients: A clinical and molecular biological study.J. Dermatol. Sci., 2, 139 (1991).
Euvrard, S., Chardonnet, Y., Pouteil-Noble, C., Kanitakis, J., Chignol, M. C., Thivolet, J., Touraine, J. L.: Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papilloma viruses in renal transplant recipients.Cancer, 72, 2198 (1993).
Hartevelt, M. M., Bavinck, J. N. B., Kootte, A. M. M., Vermeer, B. J., Vandenbroucke, J. P.: Incidence of skin cancer after renal transplantation in the Netherlands.Transplantation, 49, 506 (1990).
Strumina, R., Perini, L., Tarroni, G., Fiocchi, O., Gilli, P.: Skin lesions in kidney transplant recipients.Nephron, 62, 137 (1992).
Penn, I.: Secondary neoplasms as a consequence of transplantation and cancer therapy.Cancer Detect. Prevent., 12, 39 (1988).
Gitsch, G., Kainz, C., Pohanka, E., Reinthaller, A., Kovarik, J., Tatra, G., Breitenecker, G.: Humane Papillomavirus-Infektion der Cervix uteri bei immunsupprimierten Frauen nach Nierentransplantation.Geburtshilfe Frauenheilkd., 52, 764 (1992).
Ishikawa, I., Saito, Y., Onouchi, Z., Kitada, H., Suzuki, S., Kurihara, S. Yuri, T., Shinoda, A.: Development of acquired cystic disease and adenocarcinoma of the kidney in glomerulonephritic chronic hemodialysis patients.Clin. Nephrol., 14, 1 (1980).
Sheil, A. G. R., Flavel, S., Disney, A. P. S., Mathew, T. H.: Cancer development in patients progressing to dialysis and renal transplantation.Transplant. Proc., 17, 1685 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Winter, P., Schoeneich, G., Miersch, W.D.E. et al. Tumour induction as a consequence of immunosuppression after renal transplantation. International Urology and Nephrology 29, 701–709 (1997). https://doi.org/10.1007/BF02552189
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02552189